- Home
- OCX vs DARE Comparison
OCX vs DARE Comparison
Compare OCX & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCX
- DARE
- Stock Information
- Founded
- OCX 2009
- DARE N/A
- Country
- OCX United States
- DARE United States
- Employees
- OCX N/A
- DARE N/A
- Industry
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- OCX Health Care
- DARE Health Care
- Exchange
- OCX Nasdaq
- DARE Nasdaq
- Market Cap
- OCX 35.1M
- DARE 31.9M
- IPO Year
- OCX N/A
- DARE N/A
- Fundamental
- Price
- OCX $2.08
- DARE $3.34
- Analyst Decision
- OCX Buy
- DARE Strong Buy
- Analyst Count
- OCX 3
- DARE 4
- Target Price
- OCX $4.42
- DARE $20.33
- AVG Volume (30 Days)
- OCX 69.1K
- DARE 37.5K
- Earning Date
- OCX 11-12-2024
- DARE 11-14-2024
- Dividend Yield
- OCX N/A
- DARE N/A
- EPS Growth
- OCX N/A
- DARE N/A
- EPS
- OCX N/A
- DARE N/A
- Revenue
- OCX $709,000.00
- DARE $1,881,316.00
- Revenue This Year
- OCX N/A
- DARE N/A
- Revenue Next Year
- OCX $106.34
- DARE $136.52
- P/E Ratio
- OCX N/A
- DARE N/A
- Revenue Growth
- OCX N/A
- DARE 88.13
- 52 Week Low
- OCX $1.97
- DARE $2.67
- 52 Week High
- OCX $3.48
- DARE $7.56
- Technical
- Relative Strength Index (RSI)
- OCX 37.86
- DARE 52.30
- Support Level
- OCX $2.05
- DARE $3.03
- Resistance Level
- OCX $2.24
- DARE $3.38
- Average True Range (ATR)
- OCX 0.21
- DARE 0.12
- MACD
- OCX -0.00
- DARE 0.02
- Stochastic Oscillator
- OCX 15.28
- DARE 88.57
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.